Proton therapy is a type of radiation therapy used to treat cancer. It uses protons, which are positively charged particles, to target tumors with precision and minimize damage to healthy tissues. The global proton therapy systems market is expected to witness significant growth during the forecast period due to the increasing prevalence of cancer, technological advancements, and rising healthcare expenditure.
Market Segmentation:
The global proton therapy systems market is segmented based on type, application, and region.
Based on type, the market is segmented into single-room systems and multi-room systems. The single-room systems segment accounted for the largest market share in 2020 due to their low cost and easy installation.
Based on application, the market is segmented into pediatric cancer, prostate cancer, lung cancer, brain cancer, and others. The pediatric cancer segment accounted for the largest market share in 2020 due to the high success rate of proton therapy in treating pediatric cancers.
Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounted for the largest market share in 2020 due to the presence of a large number of key players and high adoption of proton therapy in the region.
Key Players:
The key players operating in the global proton therapy systems market include Varian Medical Systems, Inc., Hitachi, Ltd., Mevion Medical Systems, IBA Worldwide, ProTom International, Inc., Advanced Oncotherapy plc, Mitsubishi Electric Corporation, Sumitomo Heavy Industries, Ltd., ProNova Solutions, LLC, and Optivus Proton Therapy, Inc.
Recent Developments:
In April 2021, Varian Medical Systems, Inc. announced the launch of its new proton therapy system, the ProBeam 360°.
In December 2020, Hitachi, Ltd. announced the completion of its acquisition of a majority stake in the proton therapy system business of Mitsubishi Electric Corporation.
In November 2020, Mevion Medical Systems announced the launch of its new proton therapy system, the MEVION S250i Proton Therapy System.
Conclusion:
The global proton therapy systems market is expected to witness significant growth during the forecast period due to the increasing prevalence of cancer, technological advancements, and rising healthcare expenditure. The single-room systems segment accounted for the largest market share in 2020, and North America accounted for the largest market share in the same year. Key players operating in the market are focusing on product launches, partnerships, and acquisitions to strengthen their market presence.
